1. 125OPembrolizumab + chemotherapy for advanced G/GEJ adenocarcinoma (GC): The phase III KEYNOTE-062 study. (24th November 2019) Authors: Chung, H C; Bang, Y-J; Tabernero, J; Van Cutsem, E; Fuchs, C S; Wyrwicz, L; Lee, K-W; Kudaba, I; Garrido, M; Castro, H; Mansoor, W; Braghiroli, M I; Goekkurt, E; Chao, J; Wainberg, Z A; Kher, U; Shah, S; Shitara, K Journal: Annals of oncology Issue: Volume 30(2019)Supplement 9 Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. 707PEfficacy and safety of sorafenib (SFN) in elderly patients with hepatocellular carcinoma (HCC). (23rd October 2018) Authors: Gomes Da Fonseca, L; Nader Marta, G; Braghiroli, M I; Hoff, P M; Sabbaga, J Journal: Annals of oncology Issue: Volume 29(2018)Supplement 8 Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗